Viewing StudyNCT00354822



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00354822
Status: TERMINATED
Last Update Posted: 2009-09-18
First Post: 2006-07-19

Brief Title: FludarabineCyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas
Sponsor:
Organization: AO Ospedale Papa Giovanni XXIII